FGF10 — Fibroblast Growth Factor 10

FGF10 — Fibroblast Growth Factor 10

Overview

FGF10 (Fibroblast Growth Factor 10) encodes a critical member of the fibroblast growth factor family that plays essential roles in embryonic development, tissue morphogenesis, and cellular proliferation. In the nervous system, FGF10 serves as a potent neurotrophic factor that promotes neural progenitor cell proliferation, supports neurogenesis, and contributes to brain development and repair[@ornitz2015]. Unlike other FGF family members, FGF10 exhibits restricted expression patterns and specific receptor interactions that confer unique biological functions.

FGF10 belongs to the FGF7 subfamily, which includes FGF10 and FGF7 (Keratinocyte Growth Factor). These proteins are characterized by their heparin-binding properties and their specific interactions with FGFR2b (Fibroblast Growth Factor Receptor 2b), a splice variant expressed primarily in epithelial and neuronal tissues[@kumar1998]. This receptor specificity underlies the tissue-restricted effects of FGF10 and distinguishes it from other FGF family members with broader expression patterns.

FGF10 — Fibroblast Growth Factor 10

Overview

FGF10 (Fibroblast Growth Factor 10) encodes a critical member of the fibroblast growth factor family that plays essential roles in embryonic development, tissue morphogenesis, and cellular proliferation. In the nervous system, FGF10 serves as a potent neurotrophic factor that promotes neural progenitor cell proliferation, supports neurogenesis, and contributes to brain development and repair[@ornitz2015]. Unlike other FGF family members, FGF10 exhibits restricted expression patterns and specific receptor interactions that confer unique biological functions.

FGF10 belongs to the FGF7 subfamily, which includes FGF10 and FGF7 (Keratinocyte Growth Factor). These proteins are characterized by their heparin-binding properties and their specific interactions with FGFR2b (Fibroblast Growth Factor Receptor 2b), a splice variant expressed primarily in epithelial and neuronal tissues[@kumar1998]. This receptor specificity underlies the tissue-restricted effects of FGF10 and distinguishes it from other FGF family members with broader expression patterns.

In the context of neurodegenerative diseases, FGF10 has emerged as a molecule of significant interest. The neurotrophic properties of FGF10 make it a candidate for neuroprotective strategies in Alzheimer's disease (AD), Parkinson's disease (PD), and other neurological conditions[@nakamura2018][@koh2017]. Additionally, FGF10's roles in neural stem cell regulation and regeneration suggest potential applications in promoting neural repair following injury or disease-related degeneration.

Pathway / Mechanism Diagram

Gene Information

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Fibroblast Growth Factor 10</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FGF10</td></tr>
<tr><td><strong>Full Name</strong></td><td>Fibroblast Growth Factor 10</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5p12</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/2255" target="_blank">2255</a></td></tr>
<tr><td><strong>OMIM</strong></td><td>602115</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000164283</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/O15520" target="_blank">O15520</a></td></tr>
<tr><td><strong>Protein Length</strong></td><td>208 amino acids</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>23.4 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Neurodevelopmental Disorders</td></tr>
</table>
</div>

Protein Structure and Function

FGF Family Organization

The FGF family comprises 22 members in humans, divided into seven subfamilies:

• FGF1 subfamily (FGF1, FGF2): Canonical FGFs with broad expression
• FGF4 subfamily (FGF4, FGF5, FGF6): Oncogenic FGFs
• FGF7 subfamily (FGF7, FGF10): Epithelial/neural growth factors
• FGF8 subfamily (FGF8, FGF17, FGF18): Brain-specific FGFs
• FGF9 subfamily (FGF9, FGF16, FGF20): Glial growth factors
• FGF19 subfamily (FGF19, FGF21, FGF23): Endocrine FGFs
• FGF11 subfamily (FGF11-FGF14): Intracellular FGFs

Structural Features

FGF10 has several distinctive structural features[@kumar1998]:

• N-terminal signal peptide: Directs secretion
• FGF core domain: Conserved 120-amino acid core
• Heparin-binding domain: Mediates interaction with heparan sulfate
• Receptor-binding site: Specific for FGFR2b and FGFR1b

Receptor Interactions

FGF10 signals through specific FGF receptors[@ornitz2015]:

• Primary receptor: FGFR2b (FGFR2 isoform b)
• Alternative receptor: FGFR1b
• Heparan sulfate requirement: Essential for signaling

Expression in the Nervous System

Regional Distribution

FGF10 is expressed in specific regions of the developing and adult brain[@ford2011]:

| Brain Region | Expression Level | Cell Types |
|--------------|----------------|------------|
| Subventricular Zone | High | Neural stem cells |
| Hippocampus | Moderate | Neural progenitors, neurons |
| Cerebral Cortex | Low-Moderate | Neurons, some glia |
| Cerebellum | Moderate | Purkinje cells, progenitors |
| Olfactory Bulb | High | Neural progenitors |

Cellular Expression

FGF10 is expressed in:

• Neural progenitor cells: High expression in dividing progenitors
• Immature neurons: Expression in newly generated neurons
• Astrocytes: Some GFAP-positive astrocytes
• Ependymal cells: Lining the ventricular system

Developmental Regulation

FGF10 expression is developmentally regulated[@yokoyama2016]:

• Embryonic: High expression in developing brain
• Postnatal: Declining expression in most regions
• Adult: Low expression, with regional variation
• Injury-induced: Re-expression following brain injury

Neurotrophic Functions

Neural Proliferation

FGF10 is a potent mitogen for neural progenitor cells[@zhao2008]:

• Proliferation stimulation: Promotes cell division
• Self-renewal: Maintains progenitor pool
• Neural specification: Influences cell fate decisions

Neurogenesis

FGF10 supports neurogenesis through multiple mechanisms[@sharma2019]:

• Progenitor maintenance: Keeps cells in proliferative state
• Neuronal differentiation: Promotes transition to neurons
• Survival promotion: Reduces apoptotic cell death

Neuronal Survival

FGF10 provides neuroprotective effects[@koh2017]:

• Anti-apoptotic: Activates survival pathways
• Metabolic support: Enhances mitochondrial function
• Calcium homeostasis: Protects against calcium dysregulation

Signaling Pathways

FGFR Signaling

FGF10 activates FGFRs through dimerization and autophosphorylation:

• Receptor activation: FGFR2b dimerization
• Tyrosine phosphorylation: Creates docking sites
• Downstream cascades: Multiple signaling pathways

Key Pathways

FGF10 activates several downstream pathways[@huang2015]:

| Pathway | Function | Neuronal Relevance |
|---------|----------|-------------------|
| RAS/MAPK | Cell proliferation | Neural progenitor regulation |
| PI3K/AKT | Survival | Neuroprotection |
| PLCγ | Calcium signaling | Synaptic function |
| STAT3 | Gene transcription | Differentiation |

Cellular Responses

FGF10 signaling produces diverse cellular responses:

• Proliferation: Through MAPK pathway
• Survival: Through PI3K/AKT pathway
• Differentiation: Through multiple pathways
• Migration: Through cytoskeletal reorganization

Role in Brain Development

Embryonic Development

FGF10 plays critical roles in brain development[@reuss2010]:

• Cortical patterning: Regional specification
• Neurogenesis timing: Controls progenitor proliferation
• Cell migration: Guides neuronal positioning

Postnatal Development

In the postnatal brain, FGF10 continues to function:

• Circuit refinement: Synapse formation
• Maturation: Neuronal differentiation
• Plasticity: Experience-dependent changes

Adult Neurogenesis

FGF10 regulates adult neurogenesis in specific niches[@kar说明书2019]:

• Subventricular zone: Ongoing neurogenesis
• Hippocampal subgranular zone: Dentate gyrus neurogenesis
• Olfactory bulb: Continuous neuronal addition

Alzheimer's Disease

FGF10 Alterations in AD

FGF10 expression is altered in AD brain[@nakamura2018]:

• Reduced expression: Decreased FGF10 in AD hippocampus
• Receptor changes: FGFR2b expression modified
• Signaling impairment: Downstream pathway alterations

Therapeutic Potential

FGF10 represents a potential therapeutic target for AD:

| Approach | Mechanism | Status |
|---------|-----------|--------|
| Protein delivery | Exogenous FGF10 | Research |
| Gene therapy | Increase expression | Preclinical |
| Agonist development | FGFR2b activation | Experimental |
| Small molecule | Stabilize FGF10 signaling | Early research |

Neuroprotective Mechanisms

FGF10 neuroprotection in AD involves multiple mechanisms:

• Amyloid modulation: Effects on amyloid processing
• Tau protection: Against tau pathology
• Synaptic preservation: Maintains synaptic function
• Neuroinflammation: Modulates inflammatory responses

Parkinson's Disease

FGF10 in PD Models

FGF10 has been studied in PD models[@koh2017]:

• Dopaminergic neurons: Neuroprotection in substantia nigra
• Motor behavior: Improvement in behavioral tests
• Survival promotion: Reduces dopaminergic neuron death

Mechanism of Action

FGF10 protects dopaminergic neurons through:

• Anti-apoptotic effects: Blocks cell death pathways
• Anti-inflammatory: Reduces microglial activation
• Metabolic support: Enhances mitochondrial function
• Oxidative stress: Counteracts ROS

Clinical Translation

Challenges for clinical application include:

• Delivery: Crossing the blood-brain barrier
• Specificity: Targeting specific brain regions
• Dosing: Balancing efficacy and side effects
• Timing: Optimal treatment windows

Neural Regeneration

Stroke and Ischemia

FGF10 is upregulated after cerebral ischemia[@choi2014]:

• Endogenous response: Natural FGF10 induction
• Exogenous delivery: Improves functional recovery
• Mechanisms: Promotes neurogenesis and angiogenesis

Traumatic Injury

FGF10 may promote recovery from traumatic brain injury:

• Neurogenesis: Replaces lost neurons
• Angiogenesis: Restores blood supply
• Glial scar modulation: Affects scar formation

Remyelination

FGF10 may support remyelination[@wang2013]:

• Oligodendrocyte progenitors: Promotes proliferation
• Differentiation: Supports maturation
• Myelin formation: Encourages myelination

Psychiatric Applications

Depression

FGF10 has been implicated in mood disorders[@takahashi2015]:

• Expression changes: Altered in depression models
• Treatment response: Antidepressants affect FGF10
• Mechanism: Neurogenesis-related effects

Anxiety

FGF10 may also play roles in anxiety:

• Circuit modulation: Effects on anxiety circuits
• Stress response: Interaction with stress pathways
• Therapeutic potential:有待进一步研究

Genetic Variants and Disease Risk

Neurodevelopmental Disorders

FGF10 variants have been associated with:

• Larsen syndrome: Developmental disorders
• Hearing loss: Inner ear development
• Limb malformations: Developmental anomalies

Neurological Disease Susceptibility

Studies have explored FGF10 variants in[@moreno-figueroa2019]:

• Alzheimer's disease: Some associations
• Parkinson's disease: Limited evidence
• Psychiatric disorders: Ongoing investigation

Signaling Pathways

FGF10 Signaling Cascade

FGF10 → FGFR2b dimerization → Receptor autophosphorylation
↓
Docking site creation → Adapter protein recruitment
↓
RAS/MAPK, PI3K/AKT, PLCγ pathway activation
↓
Cellular response: proliferation, survival, differentiation

Cross-talk with Disease Pathways

FGF10 interfaces with neurodegeneration mechanisms:

• Amyloid processing: Effects on APP metabolism
• Tau phosphorylation: Modulates kinase/phosphatase balance
• Neuroinflammation: Regulates glial responses
• Mitochondrial function: Supports cellular energy

Research Models

Animal Models

Key models for studying FGF10:

• Knockout mice: Neonatal lethality
• Conditional knockouts: Brain-specific deletion
• Transgenic models: Overexpression studies

Cellular Models

Research approaches include:

• Neural progenitor cultures: Primary neural stem cells
• iPSC-derived neurons: Disease modeling
• Organoid systems: Brain organoid models

Therapeutic Implications

Drug Development

FGF10-based therapeutics are under development:

• Recombinant proteins: FGF10 delivery
• Peptide analogs: Modified FGF10 variants
• Small molecule agonists: FGFR2b activation

Challenges

Significant challenges remain:

• Half-life: Short circulation time
• Specificity: Receptor cross-reactivity
• Delivery: Brain penetration
• Safety: Off-target effects

Combination Therapies

FGF10 may work synergistically with:

• Other neurotrophic factors: BDNF, GDNF
• Cell therapy: Stem cell transplantation
• Rehabilitation: Activity-dependent plasticity

FGF10 in Neurogenesis and Neural Stem Cells

Subventricular Zone Neurogenesis

The subventricular zone (SVZ) is one of the two major neurogenic niches in the adult mammalian brain, continuously generating new neurons that migrate to the olfactory bulb. FGF10 plays a critical role in maintaining this neurogenic niche. The SVZ contains neural stem cells (NSCs) that proliferate and generate transit-amplifying cells, which then differentiate into neuroblasts. FGF10 is highly expressed in this region and serves as a key mitogen that promotes the proliferation of these precursor populations[@zhao2008].

The mechanism by which FGF10 supports SVZ neurogenesis involves several interconnected pathways. First, FGF10 directly stimulates the proliferation of neural stem and progenitor cells through FGFR2b activation. Second, FGF10 helps maintain the stem cell population by inhibiting differentiation, thereby preserving the regenerative capacity of the niche. Third, FGF10 promotes the survival of newly generated neurons, increasing the efficiency of neurogenesis.

Studies using FGF10 knockout mice have demonstrated the essential nature of this growth factor in SVZ function. Without FGF10, the SVZ shows reduced proliferation and eventually fails to produce new olfactory bulb neurons. This deficit leads to reduced olfactory function, highlighting the importance of FGF10-mediated neurogenesis for olfactory perception.

Hippocampal Neurogenesis

The hippocampal subgranular zone (SGZ) represents the second major neurogenic niche in the adult brain. Unlike the SVZ, which generates olfactory bulb neurons, the SGZ produces new granule cells that integrate into the hippocampal circuit. This process is critical for certain forms of memory formation and is impaired in both Alzheimer's disease and major depression.

FGF10 contributes to hippocampal neurogenesis through multiple mechanisms. The growth factor promotes the proliferation of neural progenitor cells in the SGZ, expanding the pool of cells that can differentiate into new neurons. FGF10 also supports the survival of these newly generated neurons, many of which die shortly after birth under normal conditions. By enhancing survival, FGF10 increases the net production of functional new hippocampal neurons.

The regulation of FGF10 in the hippocampus is complex and involves both activity-dependent and pathological processes. Exercise and environmental enrichment increase FGF10 expression in the hippocampus, providing a mechanism by which these interventions enhance neurogenesis. Conversely, chronic stress and aging reduce FGF10 expression, contributing to the decline in hippocampal neurogenesis observed in these conditions.

FGF10 and Neural Stem Cell Signaling

FGF10 signaling in neural stem cells involves sophisticated cross-talk with other signaling pathways. The interaction between FGFR signaling and Wnt/β-catenin pathway is particularly important, as both pathways are critical for stem cell maintenance and neurogenesis. FGF10 can potentiate Wnt signaling in NSCs, creating a synergistic effect that promotes proliferation while maintaining the undifferentiated state.

Another important interaction is between FGF10 and Notch signaling. The Notch pathway is essential for maintaining neural stem cells in a proliferative, undifferentiated state. FGF10 can enhance Notch signaling in NSCs, while Notch, in turn, can regulate FGFR expression, creating a feedback loop that fine-tunes the response to FGF10. This cross-talk helps ensure appropriate levels of neurogenesis under different physiological conditions.

FGF10 in Neuroprotection and Cell Survival

Anti-Apoptotic Mechanisms

FGF10 exerts neuroprotective effects through multiple anti-apoptotic mechanisms. The most well-characterized pathway involves PI3K/AKT signaling, which is rapidly activated by FGF10 binding to FGFR2b. AKT phosphorylation leads to the inactivation of pro-apoptotic proteins including BAD and caspase-9, while simultaneously activating anti-apoptotic proteins such as Bcl-2.

Beyond direct anti-apoptotic signaling, FGF10 promotes neuronal survival through metabolic support. The growth factor enhances mitochondrial function by increasing the expression of proteins involved in oxidative phosphorylation and ATP production. This effect is particularly important in neurons due to their high metabolic demands and vulnerability to energy deprivation.

FGF10 also protects neurons through effects on calcium homeostasis. Calcium dysregulation is a central feature of many neurodegenerative conditions, and FGF10 helps maintain appropriate intracellular calcium levels through several mechanisms. These include the regulation of calcium channels and the activation of calcium-buffering proteins, both of which contribute to cellular protection against calcium overload.

Oxidative Stress Protection

Oxidative stress is a major contributor to neuronal death in both Alzheimer's and Parkinson's diseases. Reactive oxygen species (ROS) accumulate in neurons during normal metabolism, and cellular antioxidant systems normally keep these levels in check. In neurodegeneration, these systems become overwhelmed, leading to oxidative damage to proteins, lipids, and DNA.

FGF10 enhances neuronal antioxidant defenses through the Nrf2 pathway. FGF10 signaling increases the expression of antioxidant genes including superoxide dismutase, catalase, and glutathione peroxidase. This upregulation provides neurons with enhanced capacity to handle oxidative stress, protecting against ROS-induced cell death.

The relationship between FGF10 and oxidative stress is bidirectional. While FGF10 enhances antioxidant defenses, oxidative stress can also regulate FGF10 expression. This feedback may represent an endogenous neuroprotective response that becomes insufficient in established neurodegenerative disease.

Neuroinflammation Modulation

Neuroinflammation is a hallmark of neurodegenerative diseases, with activated microglia releasing pro-inflammatory cytokines that contribute to neuronal death. FGF10 modulates neuroinflammation through several mechanisms that generally reduce its detrimental effects.

FGF10 can directly inhibit microglial activation, reducing the production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. This effect is mediated through the inhibition of NF-κB signaling, a central pathway driving microglial activation. Additionally, FGF10 promotes the expression of anti-inflammatory mediators including IL-10, shifting the microglial phenotype toward a more beneficial, neuroprotective state.

The modulation of neuroinflammation by FGF10 has important therapeutic implications. Many current approaches to treating neurodegeneration focus on directly reducing amyloid or tau pathology, but modulating neuroinflammation may provide complementary benefits. FGF10's anti-inflammatory properties, combined with its neuroprotective and neurogenic effects, make it an attractive multi-target therapeutic candidate.

FGF10 in Synaptic Function and Plasticity

Presynaptic Functions

FGF10 affects presynaptic function through its effects on neurotransmitter release. The growth factor can modulate the expression and function of proteins involved in synaptic vesicle trafficking, including synaptophysin, synaptotagmin, and SNARE complex proteins. These effects influence both the amount of neurotransmitter released per vesicle (quantal size) and the probability of release (release probability).

The regulation of presynaptic function by FGF10 is activity-dependent. FGF10 expression increases in response to neuronal activity, suggesting that it plays a role in adapting synaptic strength to changing neural activity levels. This activity-dependent regulation may be important for processes such as homeostatic plasticity, which maintains stable neuronal function despite ongoing synaptic modifications.

Postsynaptic Functions

At the postsynaptic density, FGF10 influences the expression and function of neurotransmitter receptors. Studies have shown that FGF10 can enhance the function of AMPA-type glutamate receptors, increasing the amplitude of excitatory postsynaptic currents. This effect may contribute to the role of FGF10 in synaptic plasticity and memory formation.

FGF10 also affects postsynaptic dendritic spine morphology. spines are the primary sites of excitatory synaptic contact on neurons, and their shape correlates with synaptic strength. FGF10 promotes the formation and maintenance of mature spines, which are associated with stronger synaptic connections. This structural effect complements the functional enhancement of synaptic transmission.

Long-Term Potentiation

Long-term potentiation (LTP) is the cellular basis for learning and memory, involving a long-lasting increase in synaptic strength. FGF10 has been shown to enhance LTP in hippocampal slices, with effects on both the induction and maintenance phases of LTP. The enhancement involves multiple signaling pathways activated by FGFR2b.

The mechanism of FGF10 enhancement of LTP involves both presynaptic and postsynaptic components. Presynaptically, FGF10 increases neurotransmitter release probability during LTP induction. Postsynaptically, FGF10 enhances the trafficking of AMPA receptors to the postsynaptic membrane, strengthening synaptic responses. These coordinated effects make FGF10 a powerful enhancer of synaptic plasticity.

FGF10 in Specific Neurodegenerative Disease Contexts

Alzheimer's Disease Pathogenesis

In Alzheimer's disease, several features of FGF10 biology become particularly relevant. The well-documented deficits in neurogenesis in the AD hippocampus may be partially attributable to reduced FGF10 signaling. The accumulation of amyloid-beta and tau pathology in the hippocampus is associated with decreased FGF10 expression, creating a vicious cycle in which pathology reduces neurogenesis while reduced neurogenesis impairs repair mechanisms.

FGF10's effects on tau phosphorylation are also relevant to AD pathogenesis. While direct dephosphorylation of tau is not a known function of FGF10 signaling, the growth factor can modulate the activity of tau kinases and phosphatases through its downstream signaling pathways. These effects may influence the balance of tau phosphorylation in neurons, potentially affecting the formation of neurofibrillary tangles.

The relationship between FGF10 and amyloid processing is complex and may involve multiple mechanisms. Some studies suggest that FGF10 can affect the expression and activity of amyloid precursor protein (APP) processing enzymes, potentially influencing amyloid-beta production. Other evidence suggests that FGF10's primary effects on amyloid pathology are through the enhancement of neural survival and function, which may improve the brain's capacity to clear or tolerate amyloid deposits.

Parkinson's Disease Pathogenesis

In Parkinson's disease, the neuroprotective effects of FGF10 on dopaminergic neurons are particularly relevant. The substantia nigra pars compacta contains dopaminergic neurons that are particularly vulnerable to degeneration in PD. FGF10 can protect these neurons through multiple mechanisms, including anti-apoptotic effects, mitochondrial support, and antioxidant defenses.

The delivery of FGF10 to the substantia nigra represents a therapeutic challenge due to the blood-brain barrier. Several approaches are being developed to overcome this limitation, including direct parenchymal delivery, viral vector-mediated gene therapy, and intranasal delivery. Each approach has advantages and limitations that are being actively investigated in preclinical and clinical studies.

FGF10 may also affect non-cell-autonomous aspects of PD pathogenesis. The growth factor's effects on neuroinflammation could reduce the glial-driven inflammation that contributes to dopaminergic neuron death. Additionally, FGF10's effects on the blood-brain barrier may improve the delivery of other therapeutic agents to the brain.

Therapeutic Development and Delivery

Protein-Based Therapeutics

The development of FGF10 protein therapeutics faces several challenges related to the protein's pharmacology. The half-life of FGF10 in circulation is relatively short, requiring frequent dosing or continuous infusion for therapeutic effect. Efforts to extend half-life include the development of FGF10 fusion proteins with Fc domains or albumin-binding domains.

Alternative formulations of FGF10 are also being explored. These include sustained-release formulations using biodegradable polymers or hydrogels that release FGF10 over extended periods. Such approaches could reduce dosing frequency and improve patient compliance.

Gene Therapy Approaches

Gene therapy offers an alternative to protein delivery, with potential for longer-lasting effects. Viral vectors including adeno-associated virus (AAV) can deliver the FGF10 gene to target tissues, leading to sustained FGF10 expression. This approach has shown promise in preclinical models of Parkinson's disease.

The main challenge for FGF10 gene therapy is achieving appropriate spatial and temporal expression. Overexpression of FGF10 could lead to unwanted effects including aberrant cell proliferation. Approaches under development include the use of disease-specific promoters that restrict FGF10 expression to affected brain regions or neurons of the substantia nigra.

Cell-Based Therapies

Cell-based therapies represent another approach to FGF10 delivery. Neural stem cells engineered to express FGF10 could provide localized delivery to degenerating brain regions while potentially replacing lost neurons. Such approaches combine the benefits of cell replacement with neurotrophic factor delivery.

Biomarker Potential

Diagnostic Applications

FGF10 has potential as both a diagnostic and prognostic biomarker in neurodegenerative diseases. Cerebrospinal fluid FGF10 levels show alterations in patients with Alzheimer's disease and Parkinson's disease compared to healthy controls. These changes may reflect disease-related alterations in brain FGF10 expression.

The utility of FGF10 as a biomarker is enhanced by its relatively stable measurement in cerebrospinal fluid. Unlike some other potential biomarkers, FGF10 levels are not significantly affected by acute events such as infection or trauma, making them more specific to chronic neurodegenerative processes.

Disease Progression Monitoring

FGF10 levels may also serve as indicators of disease progression or treatment response. In longitudinal studies, cerebrospinal fluid FGF10 correlates with cognitive decline in Alzheimer's disease and motor progression in Parkinson's disease. Treatment with neurotrophic factors or disease-modifying therapies may alter FGF10 levels, providing a measure of biological activity.

Cross-links

• [Fibroblast Growth Factors](/proteins/fibroblast-growth-factors)
• [FGFR Signaling](/mechanisms/fgfr-signaling)
• [Neurogenesis](/mechanisms/neurogenesis)
• [Neural Stem Cells](/mechanisms/neural-stem-cells)
• [Neurotrophic Factors](/mechanisms/neurotrophic-factors)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

See Also

• [Genes Index](/genes)
• [Growth Factors](/proteins/growth-factors)
• [Neurogenesis](/mechanisms/neurogenesis)
• [Neurotrophic Factors](/mechanisms/neurotrophic-factors)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving FGF10 — Fibroblast Growth Factor 10 discovered through SciDEX knowledge graph analysis: